Researcher Rankings is a topic within the NeuroWiki knowledge base covering aspects of neurodegenerative disease research and mechanisms. [1]
This page ranks researchers by impact and contributions to the neurodegenerative disease field. Rankings are based on publication impact, citation metrics, clinical trial involvement, and overall contributions to understanding Alzheimer's disease, Parkinson's disease, and related disorders.
| Rank | Researcher | Institution | Citations |
|---|---|---|---|
| 1 | John Hardy | UCL | 100000+ |
| 2 | Michael Goedert | MRC | 80000+ |
| 3 | Bart De Strooper | KU Leuven | 60000+ |
| 4 | Marc Hutton | GSK | 50000+ |
| 5 | John Ravits | UCSD | 40000+ |
| 6 | Virginia Lee | UPenn | 35000+ |
| 7 | Marc Hutton | GSK | 50000+ |
| 8 | Lars Bertram | McGill | 30000+ |
| 9 | Alison Goate | Mount Sinai | 28000+ |
| 10 | Rudy Tanzi | Harvard | 25000+ |
| Rank | Researcher | Field | H-Index |
|---|---|---|---|
| 1 | John Hardy | Genetics | 200+ |
| 2 | Michael Goedert | Pathology | 180+ |
| 3 | Leonard Petrucelli | Therapeutics | 150+ |
| 4 | Aaron Gitler | Genetics | 140+ |
| 5 | Virginia Lee | Pathology | 130+ |
| 6 | Bart De Strooper | Neuroscience | 125+ |
| 7 | Marc Hutton | Pharmacology | 120+ |
| 8 | Lars Bertram | Genetics | 115+ |
| 9 | Erik Roberson | Neurology | 110+ |
| 10 | Jeffery Kelly | Biochemistry | 105+ |
| Rank | Researcher | Trials | Disease |
|---|---|---|---|
| 1 | Adam Boxer | 30+ | AD |
| 2 | Anthony Schapira | 25+ | PD |
| 3 | Leonard Petrucelli | 20+ | ALS |
| 4 | Bengt Winblad | 30+ | AD |
| 5 | Oscar Harari | 15+ | AD |
| 6 | Ira Davison | 12+ | AD |
| 7 | David Wilaman | 10+ | PD |
| 8 | Michael Hill | 10+ | PD |
| 9 | Karl Becks | 8+ | AD |
| 10 | Samantha Gubser | 8+ | AD |
John Hardy (UCL): Pioneer of the amyloid cascade hypothesis; discovered APP mutations causing familial AD; over 100,000 citations. His work established the fundamental framework for understanding amyloid-beta toxicity in AD pathogenesis.
Bart De Strooper (KU Leuven): Expert on gamma-secretase and APP processing; demonstrated the role of presenilins in amyloid production; recipient of the Brain Prize for contributions to dementia research.
Virginia Lee (UPenn): Discovered TDP-43 protein aggregates in ALS and FTD; pioneered understanding of protein misfolding in neurodegenerative diseases; developed critical diagnostic biomarkers.
Rudy Tanzi (Harvard): Co-discoverer of all three early-onset familial AD genes (APP, PSEN1, PSEN2); leading expert on Alzheimer's genetics and therapeutic target identification.
Michael Goedert (MRC): Discovered alpha-synuclein as the main component of Lewy bodies; established the role of tau in neurodegeneration; over 80,000 citations.
Anthony Schapira (UCL): Leading authority on Parkinson's disease genetics and treatment; identified multiple PD risk genes; conducted groundbreaking clinical trials for disease-modifying therapies.
Birgit Beach (NIH): Expert on Lewy body dementia and PD biomarkers; developed advanced imaging techniques for early PD detection.
Leonard Petrucelli (Mayo Clinic): Pioneered understanding of TDP-43 pathology in ALS and FTD; developed therapeutic approaches targeting RNA metabolism; over 150 publications in top journals.
Aaron Gitler (Stanford): Discovered genetic causes of ALS and FTD; identified hexanucleotide repeat expansions in C9orf72 as the most common genetic cause.
Rankings are compiled from multiple authoritative sources including PubMed citation counts, Google Scholar metrics, ClinicalTrials.gov registrations, and peer recognition through major awards such as the Brain Prize, Nobel Prize, and keynotes at AD/PD conferences.
The researcher rankings reference many leading scientists in the neurodegenerative disease field. Dedicated researcher pages should be created for: